Who
Craig C. Parker
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Surrozen; Director, vTv Therapeutics; EVP, Corp Dev & Sci Affairs, Geron; Sr VP Strategy and Corporate D, Human Genome Sciences.
In numbers
- Trades disclosed
- 55
- Buys
- 1
- Sells
- 1
- Bought
- $0
- Sold
- $302K
- Companies
- 4
- Companies where not an officer
- 1
- First trade
- 8 Aug 2011
- Last trade
- 15 Jun 2026
- Last filed
- 16 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Jun 2026filed 16 Jun 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Code A | $13K1,622 at $8.11 | filing |
| 15 Jun 2026filed 16 Jun 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Code A | $13K1,622 at $8.11 | filing |
| 4 May 2026filed 5 May 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Sold | $151K4,524 at $33.33 | filing |
| 4 May 2026filed 5 May 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Sold | $151K4,524 at $33.33 | filing |
| 1 May 2026filed 5 May 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Code M | —12,500 | filing |
| 1 May 2026filed 5 May 2026 | SRZN Surrozenoption or derivative · Biotechnology | SEC FORM 4 Code M | —12,500 at $0.00 | filing |
| 1 May 2026filed 5 May 2026 | SRZN Surrozenoption or derivative · Biotechnology | SEC FORM 4 Code M | —12,500 at $0.00 | filing |
| 1 May 2026filed 5 May 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Code M | —12,500 | filing |
| 17 Feb 2026filed 18 Feb 2026 | SRZN Surrozenoption or derivative · Biotechnology | SEC FORM 4 Code A | —242,200 at $0.00 | filing |
| 17 Feb 2026filed 18 Feb 2026 | SRZN Surrozenoption or derivative · Biotechnology | SEC FORM 4 Code A | —242,200 at $0.00 | filing |
| 17 Feb 2026filed 18 Feb 2026 | SRZN Surrozenoption or derivative · Biotechnology | SEC FORM 4 Code A | —242,200 at $0.00 | filing |
| 17 Feb 2026filed 18 Feb 2026 | SRZN Surrozenoption or derivative · Biotechnology | SEC FORM 4 Code A | —242,200 at $0.00 | filing |
| 15 Dec 2025filed 16 Dec 2025 | SRZN SurrozenBiotechnology | SEC FORM 4 Code A | $13K1,553 at $8.11 | filing |
| 13 Jun 2025filed 16 Jun 2025 | SRZN SurrozenBiotechnology | SEC FORM 4 Code A | $3,224400 at $8.06 | filing |
| 1 May 2025filed 5 May 2025 | SRZN Surrozenoption or derivative · Biotechnology | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 1 May 2025filed 5 May 2025 | SRZN Surrozenoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 24 Mar 2025filed 25 Mar 2025 | SRZN Surrozenoption or derivative · Biotechnology | SEC FORM 4 Code D | —1,474 at $0.00 | filing |
| 24 Mar 2025filed 25 Mar 2025 | SRZN Surrozenoption or derivative · Biotechnology | SEC FORM 4 Code D | —1,603 at $0.00 | filing |
| 24 Mar 2025filed 25 Mar 2025 | SRZN Surrozenoption or derivative · Biotechnology | SEC FORM 4 Code D | —5,712 at $0.00 | filing |
| 24 Mar 2025filed 25 Mar 2025 | SRZN Surrozenoption or derivative · Biotechnology | SEC FORM 4 Code D | —5,712 at $0.00 | filing |
News
Head to Head Review: Surrozen (NASDAQ:SRZN) vs. AbCellera Biologics (NASDAQ:ABCL)SRZN · tickerreport.com · 14 Oct 2026Surrozen Sees Unusually Large Options Volume (NASDAQ:SRZN)SRZN · themarketsdaily.com · 12 Oct 2026Head to Head Analysis: Whitehawk Therapeutics (NASDAQ:WHWK) vs. Surrozen (NASDAQ:SRZN)SRZN · dailypolitical.com · 10 Oct 2026
0 headlines in the last 90 days name Craig C. Parker; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.